Form 8-K - Current report:
SEC Accession No. 0001564590-15-005470
Filing Date
2015-07-16
Accepted
2015-07-16 17:00:21
Documents
1
Period of Report
2015-07-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K abio-8k_20150715.htm 8-K 22687
  Complete submission text file 0001564590-15-005470.txt   24017
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 15991966
SIC: 2835 In Vitro & In Vivo Diagnostic Substances